The Efficacy and Tolerability of Canagliflozin in Healthy Individual
Clinical trial NCT06301529 · COMPLETED
Trial details
- NCT number
- NCT06301529
- Sponsor
- AgelessRx
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-12
- Primary completion
- 2024-06-29
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.